Healthcare-Associated SARS-CoV-2 Transmission—Experiences from a German University Hospital

During the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, healthcare systems worldwide have to prevent nosocomial SARS-CoV-2 transmission while maintaining duty of care. In our study, we characterize the transmission dynamic of SARS-CoV-2 in inpatients and healthcare workers (HCWs) at the University Hospital Münster (UHM) in northwest Germany. We identified 27 cases of healthcare-associated SARS-CoV-2 infections (4 inpatients and 23 HCWs) who had contact with patients and/or HCWs without the use of adequate PPE. The contacts of these index cases were followed up for SARS-CoV-2 infection after unprotected exposure and a quantitative measure of probability of becoming infected, the attack rate, was calculated. In addition, transmission was evaluated in the context of infection control measures established during the pandemic and we compared the epidemiological data of all index cases, including symptoms and Ct values of virology test results. The overall attack rate in the hospital setting was 1.3% (inpatients 0.9%, HCWs 1.6%). However, during an outbreak, the attack rate was 25.5% (inpatients 20.0%, HCWs 29.6%). For both scenarios, HCWs had a higher attack rate illustrating their role in healthcare-associated SARS-CoV-2 transmission. Taken together, our experiences demonstrate how infection control measures can minimize the transmission of SARS-CoV-2 in the healthcare setting.

[1]  Francesco Castelli,et al.  Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics , 2020, The Lancet Infectious Diseases.

[2]  Yen-Ta Huang,et al.  Estimation of the secondary attack rate of COVID-19 using proportional meta-analysis of nationwide contact tracing data in Taiwan , 2020, Journal of Microbiology, Immunology and Infection.

[3]  Victor M Corman,et al.  Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series , 2020, The Lancet Infectious Diseases.

[4]  A. Benachi,et al.  Transplacental transmission of SARS-CoV-2 infection , 2020, Nature Communications.

[5]  I. Schröder COVID-19: A Risk Assessment Perspective , 2020, Journal of chemical health & safety.

[6]  Dong Yang,et al.  Nosocomial outbreak of COVID-19 pneumonia in Wuhan, China , 2020, European Respiratory Journal.

[7]  Yongsheng Wu,et al.  Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study , 2020, The Lancet Infectious Diseases.

[8]  H. Omran,et al.  First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric dialysis unit , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Anne Kimball,et al.  Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility , 2020, The New England journal of medicine.

[10]  J. Kühn,et al.  Umgang mit COVID-19 in der Notaufnahme , 2020, Medizinische Klinik - Intensivmedizin und Notfallmedizin.

[11]  N. Khanafer,et al.  Rapid nosocomial spread of SARS-CoV-2 in a French geriatric unit , 2020, Infection Control & Hospital Epidemiology.

[12]  Nan Wang,et al.  Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Yang Liu,et al.  Secondary attack rate and superspreading events for SARS-CoV-2 , 2020, The Lancet.

[14]  P. Vollmar,et al.  Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany , 2020, The New England journal of medicine.

[15]  Victor M Corman,et al.  Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[16]  V. Munster,et al.  Nosocomial Transmission of Emerging Viruses via Aerosol-Generating Medical Procedures , 2019, Viruses.

[17]  E. Jung,et al.  Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study , 2015, BMC Medicine.

[18]  K. Shaw The 2003 SARS outbreak and its impact on infection control practices , 2005, Public Health.

[19]  R. May,et al.  Dimensions of superspreading , 2005, Nature.

[20]  J. Sung,et al.  Nosocomial transmission of SARS , 2003, Current infectious disease reports.

[21]  D. Jeffries,et al.  Nosocomial Spread of Viral Disease , 2001, Clinical Microbiology Reviews.

[22]  World Health Organization,et al.  Transmission of SARS-CoV-2: implications for infection prevention precautions , 2020 .